Xiaoming Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoming Li has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Wanmin Liu
Department of Radiology Ruijin Hospital College of Health Science and Technology Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publications Wei Chen
2 shared publications- Wenjie Zou
Department of Radiology School of Medicine Tongji Hospital Tongji University Shanghai China
2 shared publications Yiman Li
T Magnetic Resonance Translational Medicine Research Center Department of Radiology The First Affiliated Hospital of Army Medical University Chongqing China
2 shared publications- Zhehan Shen
Department of Radiology & Faculty of Medical Imaging Technology Ruijin Hospital College of Health Science and Technology Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publications - Feng Chen
Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
1 shared publication
Latest Publications
- 20 November 2026
- Published by Elsevier in Biomedical Signal Processing and Control
- Vol. 131
Triple-Phase Sequential Fusion Network with contrast enhancement kinetics for hepatobiliary-phase liver MRI synthesis
- 20 November 2026
- Published by Elsevier in Biomedical Signal Processing and Control
- Vol. 131
Triple-Phase Sequential Fusion Network with contrast enhancement kinetics for hepatobiliary-phase liver MRI synthesis
- Open Access
- 18 October 2026
- Published by Wiley in Advanced Science
Foundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.
- 18 October 2026
- Published by Wiley in Advanced Science
Open AccessFoundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.
- Open Access
- 2 October 2026
- Published by Springer Nature in npj Precision Oncology
MAVEN: an automated multimodal framework for predicting VETC and early recurrence in HCC
- 2 October 2026
- Published by Springer Nature in npj Precision Oncology
Open AccessMAVEN: an automated multimodal framework for predicting VETC and early recurrence in HCC